FR1857M - New drug in particular for the treatment of diseases of viral origin. - Google Patents

New drug in particular for the treatment of diseases of viral origin.

Info

Publication number
FR1857M
FR1857M FR890444A FR890444A FR1857M FR 1857 M FR1857 M FR 1857M FR 890444 A FR890444 A FR 890444A FR 890444 A FR890444 A FR 890444A FR 1857 M FR1857 M FR 1857M
Authority
FR
France
Prior art keywords
diseases
treatment
new drug
viral origin
viral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR890444A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Priority to FR890444A priority Critical patent/FR1857M/en
Application granted granted Critical
Publication of FR1857M publication Critical patent/FR1857M/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
FR890444A 1962-03-08 1962-03-08 New drug in particular for the treatment of diseases of viral origin. Expired FR1857M (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR890444A FR1857M (en) 1962-03-08 1962-03-08 New drug in particular for the treatment of diseases of viral origin.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR890444A FR1857M (en) 1962-03-08 1962-03-08 New drug in particular for the treatment of diseases of viral origin.

Publications (1)

Publication Number Publication Date
FR1857M true FR1857M (en) 1963-06-10

Family

ID=87571584

Family Applications (1)

Application Number Title Priority Date Filing Date
FR890444A Expired FR1857M (en) 1962-03-08 1962-03-08 New drug in particular for the treatment of diseases of viral origin.

Country Status (1)

Country Link
FR (1) FR1857M (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4049795A (en) * 1971-05-14 1977-09-20 Centre D'etudes Experimentales Et Cliniques De Physio Biologie De Pharmacologie Et D'eutonologie Treatment of hemorrhagic shock
EP0804181A1 (en) * 1995-09-19 1997-11-05 Cellular Sciences, Inc. Method and composition for treating mammalian diseases caused by inflammatory response

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4049795A (en) * 1971-05-14 1977-09-20 Centre D'etudes Experimentales Et Cliniques De Physio Biologie De Pharmacologie Et D'eutonologie Treatment of hemorrhagic shock
EP0804181A1 (en) * 1995-09-19 1997-11-05 Cellular Sciences, Inc. Method and composition for treating mammalian diseases caused by inflammatory response
EP0804181A4 (en) * 1995-09-19 2005-02-02 Cellular Sciences Inc Method and composition for treating mammalian diseases caused by inflammatory response

Similar Documents

Publication Publication Date Title
FR3069M (en) New drug, in particular for the treatment of protein anabolic disorders.
FR1958M (en) New drug in particular for the treatment of andropause, senescence and disorders of protein anabolism and cell building.
FR2963M (en) New drug, in particular for the treatment of protein anabolic disorders.
FR1857M (en) New drug in particular for the treatment of diseases of viral origin.
FR3845M (en) New drug in particular for the treatment of hypercholesterolemia and the resulting disorders.
FR1438M (en) New drug effective in the treatment of atherosclerosis.
FR2193M (en) New drug for the treatment of infectious diseases.
FR1489M (en) 4,4 'substituted diphenlysulfones and pharmaceutical preparations thereof for the treatment of viral diseases.
FR3395M (en) New drug, in particular for the treatment of neurodepressive states and anxiety psychoses.
FR1764M (en) New drug in particular for the treatment of spasms of coronary or visceral origin.
FR1780M (en) New drug in particular for the treatment of disorders of protein anabolism.
BE598692A (en) New drug for the treatment of virus diseases, especially influenza
FR2413M (en) New drug, in particular for the treatment of inflammatory and painful manifestations.
FR3096M (en) New drug in particular for the treatment of states of adynamia.
FR2681M (en) New drug in particular for the treatment of spasms of coronary origin.
FR1946M (en) New drug in particular for the treatment of spasms of coronary origin.
FR2458M (en) New drug in particular for the treatment of depressive states or anxiety.
FR1512M (en) New drug in particular for the treatment of arterial hypertension.
FR1466M (en) New drug in particular for the treatment of arterial hypertension.
FR1122M (en) New drug in particular for the treatment of hypercholesterolemia.
BE630069A (en) Therapeutic composition for the treatment of parkinsonism.
FR2467M (en) New drug in particular for the treatment of neuro-depressive states and anxiety psychoses.
FR31M (en) New drug in particular for the treatment of arterial hypertension.
FR2264M (en) Preparation for the treatment of skin diseases.
FR2805M (en) New drug in particular for the treatment of affections of bacterial origin.